Table 3.
Number of ICSRs without other suspected/interacting/concomitant drugs.
| Statins | Number of ICSRs That Do Not Mention Another Suspected Drug/Interacting Drug (%) | Number of ICSRs That Do Not Mention Another Concomitant Drug (%) | 
|---|---|---|
| Atorvastatin | 1983 (54.20) | 1765 (48.24) | 
| Simvastatin | 557 (23.95) | 809 (34.78) | 
| Rosuvastatin | 845 (43.07) | 764 (38.94) |